Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ithar Gataa"'
Autor:
Sarah El Mershati, Sixtine De Percin, François Goldwasser, Rui Batista, Audrey Thomas-Schoemann, Pascaline Boudou-Rouquette, Clémentine Villeminey, Anthia Monribot, Anne Catherine Piketty, Benoit Blanchet, David Balakirouchenane, Ithar Gataa, Jérôme Alexandre, Anne Jouinot, Audrey Bellesoeur, Michel Vidal, Camille Tlemsani
Publikováno v:
Cancer Chemotherapy and Pharmacology. 88:741-751
The risk of drug–drug interactions (DDI) has become a major issue in cancer patients. However, data in sarcoma patients are scarce. We aimed to evaluate the frequency and the factors associated with DDI with antitumor treatments, and to evaluate th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf068fc574619aaa3b023f90db4f0db0
https://doi.org/10.1007/s00280-021-04311-4
https://doi.org/10.1007/s00280-021-04311-4
Autor:
Audrey Bellesoeur, Ithar Gataa, Anne Jouinot, Sarah El Mershati, Anne Catherine Piketty, Camille Tlemsani, David Balakirouchenane, Anthia Monribot, Michel Vidal, Rui Batista, Sixtine De Percin, Clementine Villeminey, Jerome Alexandre, Francois Goldwasser, Benoit Blanchet, pascaline Boudou-Rouquette, Audrey Thomas-Schoemann
Publikováno v:
Cancer chemotherapy and pharmacology. 88(4)
Background: The risk of drug drug interactions (DDI) has become a major issue in cancer patient care. However, data in sarcoma patients are scarce. We aimed to evaluate the frequency of DDI with antitumor treatments, identify the risk factors for DDI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abe2f4f20f3d54b0f969b7b05187f7e5
https://pubmed.ncbi.nlm.nih.gov/34304283
https://pubmed.ncbi.nlm.nih.gov/34304283
Autor:
Virginia Bluthgen, Morgane Masson, Mathieu Rouanne, Julie Massé, Frank Aboubakar, Ithar Gataa, Myriam Kossai, Edouard Auclin, Laura Mezquita, Lizza E.L. Hendriks, David Planchard, Caroline Caramella, Pierre Alemany, Jean-Pierre Pignon, Anas Gazzah, Nina Radosevic-Robin, Sylvestre Le Moulec, Benjamin Besse, Julien Adam, Caroline Rossoni
Publikováno v:
European Journal of Cancer, 145, 221-229. ELSEVIER SCI LTD
Background: The established role of morphological evaluation of tumour-infiltrating lymphocytes (TILs) with immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) is unknown. We aimed to determine TIL association with the outcome f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45a672bbab27fa4aa7f4e6cd40e82f7
https://cris.maastrichtuniversity.nl/en/publications/dfb923fb-1680-4ede-8b15-dc723958492e
https://cris.maastrichtuniversity.nl/en/publications/dfb923fb-1680-4ede-8b15-dc723958492e
Autor:
Johanna Noel, Anne Jouinot, Jérôme Alexandre, Guillaume Ulmann, Marie Bretagne, Zahra Castel-Ajgal, Sixtine De Percin, Clémentine Vaquin-Villeminey, Marie-Pierre Revel, Michael Peyromaure, Pascaline Boudou-Rouquette, Jennifer Arrondeau, Ithar Gataa, Jean-Philippe Durand, François Goldwasser, Olivier Huillard
Publikováno v:
Cancers; Volume 14; Issue 13; Pages: 3214
Background: Nivolumab improved patients’ survival in metastatic renal cell carcinoma (mRCC). We aimed to evaluate resting energy expenditure (REE) (i.e., patients’ basal metabolism) to predict efficacy. Methods: We conducted a monocentric, observ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9368ac58abf21f1ca4ca8f08d616b9b8
https://doi.org/10.3390/cancers14133214
https://doi.org/10.3390/cancers14133214